Wegovy 0.25mg in stock: the legal, clinical route to getting it in the UK

What the official guidance says about starting Wegovy at 0.25mg

The 0.25mg dose is defined in Wegovy's licensed schedule (confirmed in the Wegovy Summary of Product Characteristics on the eMC) as a starting dose that allows the body to adjust before titration continues. Clinical trials established this schedule carefully: STEP 1, published in the New England Journal of Medicine, showed an average body-weight reduction of around 15% over 68 weeks at the 2.4mg maintenance dose, reached through exactly this kind of gradual step-up. The 0.25mg pen is the first rung of that journey. It is not a therapeutic dose in itself; it is the body's introduction to semaglutide. Your prescriber sets the pace of any future changes based on how you respond and any side effects you experience. Dose decisions belong with a clinician, not a dosing chart on a forum. That is worth stating plainly, because a significant number of people searching for specific Wegovy doses are trying to self-manage titration they sourced elsewhere, which is a safety concern our prescribers take seriously. Starting correctly matters as much as starting at all.

The only legal route to Wegovy 0.25mg in the UK, and what it involves

Wegovy is a prescription-only medicine under the Human Medicines Regulations 2012. The sole lawful route is a valid prescription, written by a qualified prescriber who has assessed your suitability. At nume, that process starts with a free online consultation, reviewed the same working day by a GPhC-registered Independent Prescriber, visit our about us page to see how our clinical team is structured. The consultation covers your medical history, current medicines, BMI, and relevant health conditions. If clinically appropriate, a prescription is issued and your treatment is dispensed from our GPhC-registered pharmacy (registration number 9012878, verifiable on the GPhC register). Medicines are sourced through the licensed UK supply chain via Novo Nordisk authorised routes. You can read more about what Wegovy treatment involves, including how eligibility is assessed, on our Wegovy overview page. The process is straightforward, but it is deliberately clinical, because suitability is genuinely individual, and a prescriber who has read your full history is the right person to confirm it.

How to check whether a pharmacy selling Wegovy 0.25mg is legitimate

Before purchasing any prescription medicine online, check the pharmacy on the GPhC's public pharmacy register. Legitimate online pharmacies are listed there with their premises registration number. If a seller cannot be found on the register, do not buy from them. The MHRA has issued repeated public warnings about counterfeit weight-loss pens circulating through social media and unofficial websites, fake pens have been found to contain incorrect or harmful substances, and enforcement operations in 2025 resulted in the seizure of around 20 million doses of illegally traded weight-loss medicines worth approximately £45 million. If you are also trying to locate genuine stock locally, our guide to finding Wegovy in stock near you covers these safety checks in more detail. Red flags to know: a seller offering Wegovy without requiring a clinical consultation, prices that sit well below the market range, or any mention of discount codes for prescription medicines. Report suspect sellers at yellowcard.mhra.gov.uk. A small saving is not worth the risk when the medicine is a POM dispensed by injection.

Eligibility for Wegovy 0.25mg: what a prescriber looks at

Wegovy is licensed for adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, or type 2 diabetes. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance. BMI alone is never the whole picture, a prescriber also considers your medical history, any contraindications, and whether Wegovy is the most appropriate option. Wegovy is not recommended during pregnancy, while breastfeeding, or when trying to conceive, and it is not licensed for under-18s. For people who prefer an injection-free option, our weight-loss treatments overview covers alternatives including the Wegovy tablet, approved by the MHRA in June 2026. If you are already partway through treatment elsewhere and want to move to the next stage, our guide to Wegovy 1mg availability and stock may be more relevant, and for those ready to begin the second pen in the titration schedule, you can check our page confirming whether Wegovy 0.5mg is currently in stock before placing your order. If you want a broader picture of availability across all doses before deciding where to start, our overview of Wegovy stock across the UK brings that information together in one place. Either way, the process begins with a consultation, your pen, if prescribed, sits in the fridge door until your weekly injection day, with the rest of your routine entirely unchanged.